Active targeting schemes for nanoparticle systems in cancer therapeutics

被引:1382
作者
Byrne, James D. [1 ]
Betancourt, Tania [2 ]
Brannon-Peppas, Lisa [1 ,3 ]
机构
[1] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA
[2] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA
[3] Appian Labs, Austin, TX USA
关键词
Active targeting; Passive targeting; Cancer therapy; Angiogenesis; Nanoparticles; Targeting moiety;
D O I
10.1016/j.addr.2008.08.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this review is to outline current major cancer targets for nanoparticle systems and give insight into the direction of the field. The major targeting strategies that have been used for the delivery of therapeutic or imaging agents to cancer have been broken into three sections. These sections are angiogenesis-associated targeting, targeting to uncontrolled cell proliferation markers, and tumor cell targeting. The targeting schemes explored for many of the reported nanoparticle systems suggest the great potential of targeted delivery to revolutionize cancer treatment. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:1615 / 1626
页数:12
相关论文
共 143 条
[1]  
*AC SOC, 2008, CANC FACTS FIG 2008
[2]  
Adams GP, 2001, CANCER RES, V61, P4750
[3]   Ligand based dendritic systems for tumor targeting [J].
Agarwal, Abhinav ;
Saraf, Surbhi ;
Asthana, Abhay ;
Gupta, Umesh ;
Gajbhiye, Virendra ;
Jain, Narendra K. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 350 (1-2) :3-13
[4]   In vitro efficacy of a sterically stabilized immunoliposomes targeted to membrane type 1 matrix metalloproteinase (MT1-MMP) [J].
Atobe, Kazutaka ;
Ishida, Tatsuhiro ;
Ishida, Emi ;
Hashimoto, Kouichi ;
Kobayashi, Hideo ;
Yasuda, Jyunko ;
Aoki, Takanori ;
Obata, Ken-ichi ;
Kikuchi, Hiroshi ;
Akita, Hidetaka ;
Asai, Tomohiro ;
Harashima, Hideyoshi ;
Oku, Naoto ;
Kiwada, Hiroshi .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (05) :972-978
[5]   Control of tumour vascular permeability [J].
Baban, DF ;
Seymour, LW .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (01) :109-119
[6]   Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature [J].
Backer, MV ;
Gaynutdinov, TI ;
Patel, V ;
Bandyopadhyaya, AK ;
Thirumamagal, BTS ;
Tjarks, W ;
Barth, RF ;
Claffey, K ;
Backer, JM .
MOLECULAR CANCER THERAPEUTICS, 2005, 4 (09) :1423-1429
[7]   An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform [J].
Bagalkot, Vaishali ;
Farokhzad, Omid C. ;
Langer, Robert ;
Jon, Sangyong .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (48) :8149-8152
[8]  
BAKER CH, 2007, ANTIANGIOGENIC CANC
[9]   Anisamide-targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells [J].
Banerjee, R ;
Tyagi, P ;
Li, S ;
Huang, L .
INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (04) :693-700
[10]   Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery [J].
Bellocq, NC ;
Pun, SH ;
Jensen, GS ;
Davis, ME .
BIOCONJUGATE CHEMISTRY, 2003, 14 (06) :1122-1132